(5-chlorothiophen-3-yl)-[1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]methanone;hydrochloride
C20H21Cl2N5OS — CID 127024126
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5-chlorothiophen-3-yl)-[1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]methanone;hydrochloride
(5-chlorothiophen-3-yl)-[1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]methanone;hydrochloride (PubChem CID 127024126) has the molecular formula C20H21Cl2N5OS and a molecular weight of 450.40 g/mol. Its IUPAC name is (5-chlorothiophen-3-yl)-[1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]methanone;hydrochloride.
Molecular Properties
| Compound Name | (5-chlorothiophen-3-yl)-[1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]methanone;hydrochloride |
|---|---|
| PubChem CID | 127024126 |
| Molecular Formula | C20H21Cl2N5OS |
| Molecular Weight | 450.40 g/mol |
| Exact Mass | 449.08 |
| IUPAC Name | (5-chlorothiophen-3-yl)-[1-[2-(cyclopropylamino)pyrido[3,4-b]pyrazin-3-yl]piperidin-4-yl]methanone;hydrochloride |
| SMILES | Cl.O=C(c1csc(Cl)c1)C1CCN(c2nc3cnccc3nc2NC2CC2)CC1 |
| InChI | InChI=1S/C20H20ClN5OS.ClH/c21-17-9-13(11-28-17)18(27)12-4-7-26(8-5-12)20-19(23-14-1-2-14)24-15-3-6-22-10-16(15)25-20;/h3,6,9-12,14H,1-2,4-5,7-8H2,(H,23,24);1H |
| InChIKey | URURYEYYKYKSHH-UHFFFAOYSA-N |
| XLogP | 4.84 |
| TPSA | 71.01 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 29 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 450.40 |
| LogP ≤ 5 | 4.84 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 127024126 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.